Yat Wai Wong
Chief Executive Officer presso JBM (HEALTHCARE) LIMITED
Patrimonio netto: 75 360 $ in data 31/03/2024
Profilo
Yat Wai Wong is currently the Chief Executive Officer & Executive Officer at JBM (Healthcare) Ltd.
Prior to this, he held positions as an Executive Director at Daewoong Pharmaceutical Co., Ltd.
from 2014 to 2017, Marketing Director-China & Japan at Coloplast (Hong Kong) Ltd.
from 2009 to 2013, Marketing Manager-OTC Generic Department at Mekim Ltd.
from 1993 to 1995, Marketing Manager-Hong Kong at Ferring Pharmaceuticals Ltd.
from 1996 to 2003, and VP-Medical & Science Affairs at KCI Hong Kong Holding Ltd.
in 2014.
Mr. Wong graduated from the University of Hong Kong in 2000 and The Hong Kong Polytechnic University in 1987.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
JBM (HEALTHCARE) LTD.
0.07% | 24/04/2024 | 620 862 ( 0.07% ) | 75 360 $ | 31/03/2024 |
Posizioni attive di Yat Wai Wong
| Società | Posizione | Inizio |
|---|---|---|
| JBM (HEALTHCARE) LIMITED | Chief Executive Officer | 22/09/2020 |
Precedenti posizioni note di Yat Wai Wong
| Società | Posizione | Fine |
|---|---|---|
| DAEWOONG PHARMACEUTICAL CO., LTD | Director/Board Member | 01/07/2017 |
| KCI Hong Kong Holding Ltd. | Corporate Officer/Principal | 01/08/2014 |
Coloplast (Hong Kong) Ltd.
 Coloplast (Hong Kong) Ltd. Medical SpecialtiesHealth Technology Part of Coloplast A/S, Coloplast (Hong Kong) Ltd. is a Chinese company that develops products and services to improve the lives of people with personal medical conditions. The private company is based in Hong Kong, Hong Kong. The company works closely with their customers to create personalized solutions to meet their unique needs. | Corporate Officer/Principal | 01/09/2013 |
Ferring Pharmaceuticals Ltd.
 Ferring Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals Ltd. manufactures and produces pharmaceutical products. It offers Zomacton (somatropin) for that treatment of growth failure in children and for girl’s diagnosed with Turners syndrome; GONAPEPTYL (triptorelin), a GnRH agonist that is used for the treatment of children with central precocious puberty; Testim (testosterone gel), a hydroalcoholic topical gel; and PENTASA (mesalazine), which is used for the treatment of inflammatory bowel diseases. The company was founded in 1975 and is headquartered in Middlesex, the United Kingdom. | Sales & Marketing | 01/09/2003 |
| Mekim Ltd. | Sales & Marketing | 01/04/1995 |
Formazione di Yat Wai Wong
| University of Hong Kong | Graduate Degree |
| The Hong Kong Polytechnic University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| DAEWOONG PHARMACEUTICAL CO., LTD | Health Technology |
| JBM (HEALTHCARE) LIMITED | Health Technology |
| Aziende private | 4 |
|---|---|
| Mekim Ltd. | |
Ferring Pharmaceuticals Ltd.
Ferring Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals Ltd. manufactures and produces pharmaceutical products. It offers Zomacton (somatropin) for that treatment of growth failure in children and for girl’s diagnosed with Turners syndrome; GONAPEPTYL (triptorelin), a GnRH agonist that is used for the treatment of children with central precocious puberty; Testim (testosterone gel), a hydroalcoholic topical gel; and PENTASA (mesalazine), which is used for the treatment of inflammatory bowel diseases. The company was founded in 1975 and is headquartered in Middlesex, the United Kingdom. | Health Technology |
Coloplast (Hong Kong) Ltd.
Coloplast (Hong Kong) Ltd. Medical SpecialtiesHealth Technology Part of Coloplast A/S, Coloplast (Hong Kong) Ltd. is a Chinese company that develops products and services to improve the lives of people with personal medical conditions. The private company is based in Hong Kong, Hong Kong. The company works closely with their customers to create personalized solutions to meet their unique needs. | Health Technology |
| KCI Hong Kong Holding Ltd. |
- Borsa valori
- Insiders
- Yat Wai Wong
